Article
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
18 Jan 2018
Abstract excerpt
Malignant mesothelioma (MM) is poorly responsive to systemic cytotoxic chemotherapy and invariably fatal. Here we describe a screen of 94 drugs in 15 exome-sequenced MM lines and the discovery of a subset defined by loss of function of the nuclear deubiquitinase BRCA associated protein-1 (BAP1) that demonstrate heightened sensitivity to TRAIL (tumour necrosis factor-related apoptosis-inducing ligand). This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
